LianBio - stock earnings
LIAN Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -24.0 million USD | ? USD |
| 2023Q2 | -21.6 million USD | ? USD |
| 2023Q1 | -24.0 million USD | ? USD |
| 2022Q4 | -18.3 million USD | ? USD |
| 2022Q3 | -21.9 million USD | ? USD |
| 2022Q2 | -42.4 million USD | ? USD |
| 2022Q1 | -27.7 million USD | ? USD |
| 2021Q4 | -21.2 million USD | ? USD |
| 2021Q3 | -13.1 million USD | ? USD |
| 2021Q2 | -100.4 million USD | ? USD |
| 2021Q1 | -61.6 million USD | ? USD |
| 2020Q4 | -12.7 million USD | ? USD |
| 2020Q3 | -120.2 million USD | ? USD |
LIAN Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -88.0 million USD | ? USD |
| 2022 | -110.3 million USD | ? USD |
| 2021 | -196.3 million USD | ? USD |
| 2020 | -139.6 million USD | ? USD |
| 2019 | -24.4 million USD | ? USD |
LIAN
Price: $0.32
52 week price:
5-year range yield:
Forward Dividend Yield: 1504.70%
Payout Ratio: -585.37%
Payout Ratio Range:
Dividend Per Share: 4.80 USD
Earnings Per Share: -0.82 USD
P/E Ratio: -4.99
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 104000
Market Capitalization: 34.5 million
Years Paying Dividends: 1